The goal of this study was to test the hypoth esis that administration of L-arginine, a substrate for the synthesis of nitric oxide, restores endothelium-dependent dilatation of the basilar artery during diabetes mellitus. We measured the diameter of the basilar artery in vivo in nondiabetic and diabetic (streptozotocin; 50-60 mg/kg i.p.) rats in response to endothelium-dependent agonists (acetylcholine and bradykinin) and an endothelium-inde pendent agonist (nitroglycerin) before and during appli cation of L-arginine. Topical application of acetylcholine (1.0 and 10 floM) and bradykinin (1.0 and 10 floM) produced dilatation in nondiabetic rats of the basilar artery which Abbreviations used: CSF, cerebrospinal fluid; EDRF, endo thelium-derived relaxing factor; L-NMMA, ,vG -monomethyl-L arginine; NADPH, nicotinamide-adenine-dinucleotide phos phate.
Diabetes mellitus impairs endothelium-dependent relaxation of large and small cerebral blood vessels (Fujii et aI., 1992; Pelligrino and Albrecht, 1991; Pelligrino et aI. , 1992; Dandona et aI. , 1978; May han, 1989 May han, , 1992 May han, , 1993 Mayhan et aI. , 1991) . The mechanism(s) by which diabetes impairs endotheli um-dependent dilatation of cerebral blood vessels appear to differ. We have suggested that impaired endothelium-dependent dilatation of rat pial (cor tex) arterioles is related to the production of a cy clooxygenase constrictor substance that, presum ably, activates the prostaglandin H2/thromboxane A2 receptor (Mayhan et aI., 1991) . Other investiga tors have suggested that impaired endothelium-de pendent dilatation of rat pial arterioles was related to the activation of protein kinase-C (Pelligrino et aI., 1994) . Thus, alter a tions in several cellular path ways may account for impaired endothelium-de pendent reactivity of cerebral arterioles.
We were the first to examine endothelium-de pendent responses of the basilar artery in vivo dur ing diabetes mellitus (Mayhan, 1992) . Similar to that which we have reported for pial arterioles (Mayhan et aI. , 1991; Mayhan, 1989; Pelligrino et aI., 1994) , endothelium-dependent responses of the basilar ar tery to acetylcholine and bradykinin were pro foundly impaired in diabetic rats (Mayhan, 1992) . However, in contrast to that reported for pial arte rioles (Mayhan et aI. , 1991) , impaired dilatation of the basilar artery during diabetes mellitus could not be explained by the production of a cyclooxygenase constrictor substance and/or activation of the pros taglandin H2/thromboxane A2 receptor (Mayhan, 1992) . Thus, other cellular mechanisms must ac count for impaired endothelium-dependent dilata tion of the basilar artery during diabetes mellitus.
A recent study (Pieper and Peltier, 1995) suggests that impaired relaxation of the thoracic aorta in rats during diabetes mellitus could be enhanced by treat ment with L-arginine (3 mM), a substrate for nitric oxide synthase. Thus, it appears that impaired en dothelium-dependent responses during diabetes mellitus may be related to a decreased availability of L-arginine to nitric oxide synthase, leading to a decreased agonist-induced synthesis/release of ni tric oxide. The goal of the present study was to examine whether impaired endothelium-dependent dilatation of the basilar artery during diabetes mel litus could be enhanced by L-arginine.
METHODS

Induction of diabetes
Male Sprague-Dawley rats (200--220 g body wt) were divided randomly into nondiabetic and diabetic groups. All rats were housed in hanging cages and had access to food and water ad libitum. One group of rats was injected with streptozotocin (50--60 mg/kg i.p.) to induce diabetes. The second group of rats (nondiabetic) was injected with vehicle. Blood samples, for measurement of blood glu cose concentration, were obtained at 2 weeks after injec tion of streptozotocin or vehicle, and on the day of the experiment. Other than a failure to gain as much weight as the nondiabetic rats, there were no differences in the general condition of nondiabetic and diabetic rats.
Preparation of animals
Rats were prepared for studies at 2.5-3.5 months after injection of streptozotocin or vehicle. Rats were anesthe tized (pentobarbital sodium, 50 mg/kg body wt i.p.), and a tracheotomy performed. Animals were ventilated me chanically with room air and supplemental oxygen. A catheter was inserted into a femoral vein for injection of drugs, and a femoral artery was cannulated for measure ment of arterial pressure. Skeletal muscle paralysis was induced with gallamine triethiodide (5-10 mg/kg i.v.). Supplemental anesthesia was administered at a dose of 10--20 mg/kg/h i. v. No differences were observed between nondiabetic and diabetic rats with regard to the amount of pentobarbital and gallamine triethiodide (mg/kg body wt) required to induce/maintain anesthesia and paralysis, re spectively.
After placement of all catheters, the animal was placed in a head holder in a supine position. The larynx and esophagus were retracted rostrally and laterally and the musculature covering the basioccipital bone removed. Then, a craniotomy was made in the bone at the base of the skull. The dura was incised to expose the basilar ar tery. We (Mayhan, 1991; Mayhan, 1990b) and others (Faraci, 1990) have used this method to expose the basilar artery previously.
The cranial window was suffused with artificial cere bral spinal fluid (CSF) (38°C) and bubbled continuously to maintain gases within normal limits. Blood gases were monitored and maintained within normal limits through out the experiment.
Diameter of the basilar artery was measured on-line using a video image shearing device (Model 908, Instru mentation for Physiology and Medicine, San Diego, CA, U.S.A.).
Experimental protocol
The basilar artery preparation was allowed to equili brate for 30 min after the craniotomy. Then, we examined responses of the basilar artery in nondiabetic and diabetic rats to agonists [acetylcholine (1.0 and 10 f.LM) and brady kinin (1.0 and 10 f.LM)] that, presumably, produce dilata tion via the synthesis/release of nitric oxide or a nitric oxide-containing compound. We also examined dilatation of the basilar artery in nondiabetic and diabetic rats in response to an endothelium-independent agonist [nitro glycerin (0.1 and 1.0 f.LM)]. Drugs were mixed in artificial cerebral spinal fluid and superfused over the basilar ar tery preparation. The application of vehicle did not affect vessel diameter and the application of agonists was ran domized. The diameter of the basilar artery was mea sured immediately before the application of agonists and every min for 5 min during application of the agonists. Steady-state responses to the agonists were reached within 2-3 min after application, and the diameter of the basilar artery returned to control within 2-4 min after application of the agonists was stopped.
After examining responses to the agonists under con trol conditions, we then examined the possibility that im paired responses of the basilar artery to acetylcholine and bradykinin may be related to an alteration in the avail ability of L-arginine to nitric oxide synthase. To test this possibility, we again examined responses of the basilar artery in nondiabetic and diabetic rats to the agonists 30 min after starting a continuous topical application of L-ar ginine (0.1 or 3 mM). A previous study (Faraci, 1990) has shown that a concentration o( L-arginine similar to that used in the preseI)t study is efficacious in the basilar ar tery of rats. Vasoconstriction produced with an enzymat ic inhibitor of nitric oxide was completely reversed by 0.1 mM L-arginine (Faraci, 1990) . In additional studies, we examined the effect of D-arginine (3 mM) on responses of the basilar artery.
Statistical analysis
An unpaired {-test was used to compare values between different groups of animals. A paired {-test was used to compare responses of the basilar artery before and after application of L-arginine. A p-value of 0.05 was consid ered to be significant.
RESULTS
Control conditions
Baseline diameter of the basilar artery was 28 1 ± 35 fLm in nondiabetic rats and 318 ± 49 fLm in dia betic rats (mean ± SD; p > 0.05). Blood pressure was 114 ± 18 mm Hg in nondiabetic rats and 123 ± 19 mm Hg in diabetic rats (mean ± SD; p > 0.05). On the day of the experiment, blood glucose con centration was 106 ± 55 mg/dl in nondiabetic rats and 37 1 ± 48 mg/dl in diabetic rats (mean ± SD; p < 0.05 versus nondiabetic rats). Body weight was 412 ± 53 g in nondiabetic rats and 294 ± 55 g in diabetic rats (mean ± SD; p < 0.05 versus nondia betic rats). These values are similar to those re ported previously by us (Mayhan, 1989; Mayhan et aI., 199 1; Mayhan, 1990a) .
Responses in nondiabetic and diabetic rats
Dilatation of the basilar artery in response to ace tylcholine and bradykinin was significantly im paired during diabetes mellitus. Acetylcholine (1.0 and 10 fLM) dilated the basilar artery by 21 ± 12 and 32 ± 17% (mean ± SD) , respectively, in nondia betic rats but by only 5 ± 5 and 8 ± 6%, respec tively, in diabetic rats (p < 0.05) ( Fig. 1 ). Bradyki-nin (1.0 and 10 fA-M) dilated the basilar artery by 21 ± IS and 29 ± 17%, respectively, in nondiabetic rats, but by only 3 ± 4 and 5 ± 8%, respectively, in diabetic rats (p < 0.05) (Fig. 1) .
In contrast, nitroglycerin produced similar dose related dilatation of the basilar artery in nondiabetic and diabetic rats. Nitroglycerin (0.1 and 1.0 fA-M) dilated the basilar artery by 15 ± 9 and 27 ± 11 %, respectively, in nondiabetic rats and by 13 ± II and 24 ± 16%, respectively, in diabetic rats (p > 0.05) ( Fig. I) . Thus, impaired responses of the basilar artery to acetylcholine and bradykinin in diabetic rats cannot be explained by nonspecific impairment of vasodilatation during diabetes mellitus.
Responses fo llowing L-arginine
Topical application of L-arginine (0.1 mM) pro duced only minimal changes in baseline diameter of the basilar artery in nondiabetic ( -2 ± 3%) and diabetic ( -5 ± 7%) rats.
L-arginine (0.1 mM) did not alter dilatation of the basilar artery in nondiabetic rats in response to ace tylcholine ( Fig. 2) and bradykinin ( Fig. 3) . In addi tion, topical application of L-arginine (0.1 mM) did not enhance dilatation of the basilar artery in dia betic rats in response to acetylcholine (Fig. 2) and bradykinin ( Fig. 3 ). Furthermore, L-arginine (0.1 mM) did not alter dilatation of the basilar artery in response to nitroglycerin in nondiabetic and dia betic rats ( Fig. 4) .
Topical application of L-arginine (3.0 mM) pro duced only a minimal change in baseline diameter of the basilar artery in nondiabetic rats ( -6 ± 5%), but produced a marked decrease in baseline diam eter of the basilar artery in diabetic rats ( -15 ±. 8%).
L-arginine (3.0 mM) significantly impaired dilata tion of the basilar artery in nondiabetic rats in re sponse to acetylcholine ( ( Fig. 6 ). This paradoxical attenuation of acetylcho line-and bradykinin-induced dilatation of the basi lar artery in nondiabetic rats could not be explained by a nonspe, cific effect of L-arginine on vasodilata tion, since responses to nitroglycerin (Fig. 7) were not altered in nondiabetic rats following application of L-arginine (3.0 mM), and application of D-argi nine (3.0 mM) did not alter dilatation of the basilar artery to acetylcholine in nondiabetic rats. Acetyl choline (1.0 and 10 fA-M) dilated the basilar artery by 22 ± 9 and 35 ± 2%, respectively, before and by 22 ± 8 and 40 ± 13%, respectively, after application of D-arginine (n = 3). Topical application of L-arginine (3.0 mM) did not enhance dilatation of the basilar artery in diabetic rats in response to acetylcholine ( Fig. 5 ) and brady kinin (Fig. 6 ). Furthermore, L-arginine (3.0 mM) did not alter dilatation of the basilar artery in response to nitroglycerin in diabetic rats (Fig. 7) .
Taken together, our findings with L-arginine sug gest that an alteration in the availability of L-argi nine to nitric oxide synthase may not account for impaired dilatation of the basilar artery during dia betes mellitus. 
DISCUSSION
The major new finding of the present study is that treatment of the basilar artery with L-arginine does not restore impaired dilator responses to acetylcho line and bradykinin observed during diabetes melli tus. Thus, impaired dilatation of the basilar artery during diabetes mellitus does not appear to be re lated to an alteration in the availability of L-arginine to nitric oxide synthase, but may be related to al terations in other cellular pathways, i.e., chronic pro duction of oxygen radicals, production of advanced glycosylation end products, increased synthesis/ release of sorbitol via the polyol pathway, and/or alteration in the enzyme nitric oxide synthase.
Responses to acetylcholine and bradykinin
Several investigators have shown that acetylcho line produces marked relaxation of the basilar ar tery in rats (Lai et al., 1989; Soltis and Bohr, 1987) , rabbits (N akagomi et al., 1988; Fuji wara et aI., 1986) , cats (Hamel et al., 1988) , and humans (Kan- , 1989; Whalley et al., 1987) using in vitro met h odologies. We (Mayhan, 1990b) and oth ers (Faraci, 1990; Faraci, 1991) examined responses of the basilar artery in vivo in rats to acetylcholine. These studies found that acetylcholine produced a dose-related dilatation of the basilar artery that was inhibited by N G -monomethyl-L-arginine (L NMMA), an enzymatic inhibitor of nitric oxide syn thase (Mayhan, 1990h; Faraci, 1990; Faraci, 1991) . Thus, dilatation of the basilar artery in rats in re sponse to acetylcholine appears to be related to the release of nitric oxide or a nitric oxide-containing compound.
Bradykinin also produces relaxation of the hu man (Whalley et al. , 1987) , feline (Hamel et al., 1988) , and canine (Katusic et al., 1989) basilar ar tery in vitro. Unlike that found for pial arterioles, in which bradykinin produces dilatation via the pro duction of oxygen radicals (Kontos et al., 1984; Rosenblum, 1987) , the mechanism of relaxation of the human (Whalley et aI., 1987) and canine (Katu sic et al., 1989 ) basilar artery appears to be related to the production of an endothelium-derived relax ing factor (EDRF), presumably nitric oxide. Treat ment with indomethacin or inhibitors of oxygen rad icals does not alter relaxation of the human or ca nine basilar artery in response to bradykinin (Whalley et aI., 1987 , Katusic et aI., 1989 . We have examined the effects of bradykinin on dilatation of the rat basilar artery in vivo (Mayhan, 1990b) . We found that bradykinin produced a dose-related dila tation of the basilar artery in rats that was not af fected by treatment with indomethacin, but was in hibited by treatment with L-NMMA (Mayhan, 1990b) . Thus, these findings (Mayhan, 1990b) also suggest that dilatation of the basilar artery in re sponse to bradykinin is not related to products re leased via the cyclooxygenase pathway, but is re lated to the release of nitric oxide or a nitric oxide containing compound. Several investigators have shown that endotheli um-dependent dilatation of cerebral blood vessels is altered during diabetes mellitus (Fujii et aI. , 1992; Pelligrino and Albrecht, 199 1; Pelligrino et aI. , 1992; Dandona et aI., 1978) . However, for the most part, these studies have not examined mechanisms by which diabetes affects responses of the cerebral cir culation, and no studies have examined the effects of diabetes on the vertebrobasilar system. We have shown that endothelium-dependent dilatation of the basilar artery in response to acetylcholine and bradykinin is profoundly impaired in diabetic com pared to nondiabetic rats (Mayhan, 1992) . Impaired responses of the basilar artery to acetylcholine and bradykinin appear to be specific for endothelium dependent agonists since nitroglycerin produces similar dose-related dilatation of the basilar artery in nondiabetic and diabetic rats.
Mechanisms of impaired reactivity during diabetes
Several mechanisms have been suggested to ac count for impaired endothelium-dependent relax ation of peripheral blood vessels during diabetes mellitus, including production of a cyclooxygenase constrictor substance with subsequent activation of the prostaglandin Hz!thromboxane A2 receptor (Tesfamariam et aI., 1989; Shimizu et aI., 1993) ; a deficit in substrate (L-arginine) utilization/ availability (Pieper and Peltier, 1995) ; increased chronic production of oxygen radicals, which serve to inactivate nitric oxide (Pieper et aI., 1993; Lan genstroer and Pieper, 1992; Pieper et aI., 1992; Hat tori et aI., 1991; Pieper and Gross, 1988) ; increased production of advanced glycosylation end products (Tilton et aI., 1993; Corbett et aI., 1992; Bucala et J Cereb Blood Flow Metab, Vol. 16, No.3, 1996 a\., 1991 Brownlee et aI., 1988; Wu, 1993) ; and increased levels of sorbitol (Taylor et aI., 1994; Knudsen et aI., 1989; Tesfamariam et aI., 1993; Car rington et aI., 1993; Wakasugi et aI., 1991; Tesfa mariam, 1994) . Thus, mechanisms responsible for impaired endothelium-dependent reactivity of pe ripheral arteries appear to involve several ceIlular processes.
Mechanisms that contribute to impaired dilata tion of cerebral arteries and arterioles during diabe tes meIlitus also are not uniform. We (Mayhan et aI. , 199 1) have shown that impaired dilatation of pial arterioles in rats during diabetes meIlitus relates to the production of a cyclooxygenase constrictor substance, which presumably activates the prosta glandin Hzlthromboxane A2 receptor. However, other studies (Pelligrino et aI. , 1994) suggest that activation of protein kinase-C accounts for impaired dilatation of rat pial arterioles during diabetes mel litus. In addi t ion, we have shown that there are im portant regional differences between mechanisms that contribute to impaired responses of cerebral blood vessels during diabetes meIlitus. In contrast to that observed for pial arterioles (Mayhan et aI., 199 1) , dilatation of the basilar artery in diabetic rats could not be restored to the amount observed in nondiabetic rats with indomethacin or an antagonist of the prostaglandin Hzlthromboxane Az receptor (Mayhan, 1992) . Thus, it appears that alterations in other cellular pathways must account for impaired responses of the basilar artery during diabetes mel litus.
In the present study, we investigated whether a deficit in L-arginine availability could account for impaired dilatation of the basilar artery during dia betes mellitus. A recent study suggests that im paired relaxation of the aorta in diabetic rats could be enhanced by application of L-arginine (Pieper and Peltier, 1995) . These investigators (Pieper and Peltier, 1995) found that L-arginine (3 mM) potenti ated relaxation of the thoracic aorta to acetylcho line, but not nitroprusside, in diabetic rats. In con trast to that study, we did not find a role for L-ar ginine in altered responses of the basilar artery during diabetes mellitus. Thus, it appears that there are important regional differences between mecha nisms that account for altered responses of blood vessels during diabetes mellitus.
Surprisingly, we found that application of L-argi nine (3.0 mM) significantly impaired dilator re sponses of the basilar artery to acetylcholine and bradykinin in nondiabetic rats. This effect appeared to be specific since L-arginine (3.0 mM) did not alter dilatation of the basilar artery to nitroglycerin, and D-arginine (3.0 mM) did not alter dilatation of the basilar artery to acetylcholine and bradykinin. The mechanisms by which high concentrations of L-ar ginine alter nitric oxide-mediated dilatation of the basilar artery are not clear. It is possible that high concentrations of L-arginine may affect transmem brane flux of calcium, the arginine transporter, and/ or nitric oxide synthase. In support of this, a recent study suggests that nitric oxide may inhibit nitric oxide synthase (Assreuy et aI. , 1993) , although it is not clear whether excess L-arginine would also pro duce this effect. In addition, a recent study (MacAl lister et al., 1995) suggests that infusion of a high concentration of L-arginine 00 g/90 ml of saline i. v. over 10 min) in humans increases plasma levels of insulin, glucagon, and prolactin. Although vascular reactivity following infusion of L-arginine was not examined in the study of MacAl1ister et al. (1995) , it is possible that the above mentioned hormones may affect vascular reactivity in response to endotheli um-dependent agonists. In our study, we examined the effect of topical application of L-arginine on re activity of the basilar artery. It is not clear whether topical application of L-arginine would stimulate the synthesislrelease of factors that could affect vascu lar reactivity. Nevertheless, it appears that a high concentration of L-arginine produces modest, but selective, impairment of nitric oxide-mediated dila tation of the basilar artery.
In conclusion, this is the first study to examine the role of L-arginine in altered responses of the basilar artery to endothelium-dependent agonists during diabetes mellitus. We found that diabetes im pairs endothelium-dependent dilatation of the basi lar artery in response to acetylcholine and bradyki nin. However, impaired responses of the basilar ar tery to acetylcholine and bradykinin during diabetes could not be restored by treatment with L-arginine. Thus, it does not appear that an alteration in the availability of the substrate for nitric oxide syn thase, L-arginine, accounts for altered responses of the basilar artery during diabetes mel1itus. We sug gest that other co-factors for nitric oxide formation, e.g., nitric oxide synthase, transmembrane flux of calcium, calmodulin, nicotine-adenine-dinucleotide phosphate (NADPH), and/or alterations in other cellular processes, i.e., increased formation of ox ygen radicals and/or increased formation of sorbi tol, may account for impaired reactivity of the bas ilar artery during diabetes mellitus. tation of cerebral arterioles during diabetes mellitus. Am J PhysioI256:H6 21-H625 Mayhan WG (l990 a) Effect of diabetes mellitus on disruption of the blood-brain barrier during acute hypertension. Brain Res 534: 106-110 Mayhan WG (l990 b) Impairment of endothelium-dependent di latation of basilar artery during chronic hypertension. Am J PhysioI259 :HI455-HI462 Mayhan WG (199 1) Responses of the basilar artery to products released by platelets during chronic hypertension. Brain Res 545:9 7-10 2 Mayhan WG, Simmons LK, Sharpe GM (199 1) Mechanism of impaired responses of cerebral arterioles during diabetes mellitus. Am J Physiol 260 :H319-H326
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